714 related articles for article (PubMed ID: 11826241)
21. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
[TBL] [Abstract][Full Text] [Related]
23. A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury.
Gao WM; Chadha MS; Berger RP; Omenn GS; Allen DL; Pisano M; Adelson PD; Clark RS; Jenkins LW; Kochanek PM
J Neurotrauma; 2007 Jan; 24(1):43-53. PubMed ID: 17263669
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma resulting from ventricular drain insertion.
Brandner S; Thaler C; Buchfelder M; Kleindienst A
J Neurotrauma; 2013 Jul; 30(13):1205-10. PubMed ID: 23390981
[TBL] [Abstract][Full Text] [Related]
25. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
[TBL] [Abstract][Full Text] [Related]
27. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
28. Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs.
Potapov EV; Loebe M; Abdul-Khaliq H; Koster A; Stein J; Sodian R; Kopitz M; Hausmann H; Noon GP; DeBakey ME; Hetzer R
J Heart Lung Transplant; 2001 Dec; 20(12):1310-6. PubMed ID: 11744415
[TBL] [Abstract][Full Text] [Related]
29. Serum S100B concentrations are increased after closed head injury in children: a preliminary study.
Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Kochanek PM
J Neurotrauma; 2002 Nov; 19(11):1405-9. PubMed ID: 12490005
[TBL] [Abstract][Full Text] [Related]
30. Neural tissue-related proteins (NSE, G0 alpha, 28-kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest.
Usui A; Kato K; Murase M; Hotta T; Tanaka M; Takeuchi E; Abe T
J Neurol Sci; 1994 May; 123(1-2):134-9. PubMed ID: 8064306
[TBL] [Abstract][Full Text] [Related]
31. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
Steiner J; Bielau H; Bernstein HG; Bogerts B; Wunderlich MT
J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1284-7. PubMed ID: 17043297
[TBL] [Abstract][Full Text] [Related]
32. Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury.
Phillips DJ; Nguyen P; Adamides AA; Bye N; Rosenfeld JV; Kossmann T; Vallance S; Murray L; Morganti-Kossmann MC
J Neurotrauma; 2006 Sep; 23(9):1283-94. PubMed ID: 16958581
[TBL] [Abstract][Full Text] [Related]
33. Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.
Chabok SY; Moghadam AD; Saneei Z; Amlashi FG; Leili EK; Amiri ZM
J Trauma Acute Care Surg; 2012 Jun; 72(6):1654-7. PubMed ID: 22695436
[TBL] [Abstract][Full Text] [Related]
34. Multiple indicators model of long-term mortality in traumatic brain injury.
Gradisek P; Osredkar J; Korsic M; Kremzar B
Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
[TBL] [Abstract][Full Text] [Related]
35. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography.
Herrmann M; Jost S; Kutz S; Ebert AD; Kratz T; Wunderlich MT; Synowitz H
J Neurotrauma; 2000 Feb; 17(2):113-22. PubMed ID: 10709869
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.
Kay AD; Petzold A; Kerr M; Keir G; Thompson EJ; Nicoll JA
J Neurotrauma; 2003 Mar; 20(3):243-50. PubMed ID: 12820678
[TBL] [Abstract][Full Text] [Related]
37. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
[TBL] [Abstract][Full Text] [Related]
38. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A
Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753
[TBL] [Abstract][Full Text] [Related]
39. Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity.
Shiihara T; Miyake T; Izumi S; Watanabe M; Kamayachi K; Kodama K; Nabetani M; Ikemiyagi M; Yamaguchi Y; Sawaura N
Pediatr Int; 2012 Feb; 54(1):52-5. PubMed ID: 21883688
[TBL] [Abstract][Full Text] [Related]
40. Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis.
Elshorbagy HH; Barseem NF; Elsadek AE; Al-shokary AH; Maksoud YHA; Abdulsamea SE; Talaat IM; Suliman HA; Kamal NM; Abdelghani WE; Azab SM; El Din DMN
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):374-387. PubMed ID: 31067852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
